Browsing Category
Healthcare Industry News
2470 posts
From Verizon to Butterfly Network: Can John Doherty’s Wall Street discipline steady a medtech pioneer?
Butterfly Network (NYSE:BFLY) names Wall Street veteran John Doherty as CFO to steer the medtech innovator toward profitability and financial discipline.
Can Apogee Therapeutics convert its $300m public offering into real clinical momentum before 2028?
Discover how Apogee Therapeutics (NASDAQ: APGE) is deploying a $300 million public offering to expand its biologics pipeline and investor runway.
HealthStream buys Virsys12 in $17m deal to expand credentialing solutions for health plans
Find out how HealthStream’s $17 million Virsys12 acquisition strengthens payer credentialing, provider data, and investor sentiment.
Angle plc collapses after shock pivot: Executive chairman appointed as it rebrands to CelLBxHealth
Angle plc’s shares plunge 36 percent after rebranding as CelLBxHealth and appointing Jan Groen as executive chairman. Discover how this reset affects funding and investor outlook.
Regulatory breakthrough: What the MHRA–FDA tie-up means for medtech approvals
Find out how the MHRA–FDA collaboration is reshaping medical device regulation, AI safety, and faster patient access across the UK and US healthcare systems.
Nexalin Technology unveils breakthrough Alzheimer’s study validating non-drug Gen-2 SYNC brain stimulation
Find out how Nexalin’s Gen-2 SYNC device improved cognition in Alzheimer’s patients with non-drug 40 Hz brain stimulation.
PainChek (ASX: PCK) stock climbs on FDA approval — is this the breakout investors expected?
PainChek Ltd (ASX: PCK) gains FDA De Novo clearance for its AI pain-assessment app, sparking a stock rally and opening a US $100 million market in US aged care.
Owens & Minor sells healthcare unit to Platinum Equity for $375mn, keeps 5% stake
Find out how Owens & Minor’s $375 million sale to Platinum Equity marks a strategic shift toward home-based care and stronger financial focus.
FDA greenlights Envoy Medical’s fully implanted cochlear implant trial — could this be the biggest leap in hearing restoration yet?
Find out how Envoy Medical’s FDA-cleared Acclaim cochlear implant trial is redefining the future of fully implanted hearing technology.
Inside Johnson & Johnson’s $966m talc verdict: how one case could reshape its future battles
Find out how Johnson & Johnson’s $966 million talc cancer verdict could reshape its litigation strategy, investor sentiment, and brand credibility.